Baranov S B, Guseĭnov K D
N.N. Petrov Research Institute of Oncology, Ministry of Health of the RF, St. Petersburg.
Vopr Onkol. 2003;49(5):612-4.
The potential of preoperative radiochemotherapy in combined treatment of cervical carcinoma T1B-2ABN0-1M0 has been investigated. The use of cisplatin raised the feasibility of radical surgery from 69 to 87%, as compared with radiation alone, and increased 2-year overall and relapse-free survival to 92.6% and 89.4% vis-a-vis 80.8% and 77.8%, respectively. No increase in complication rates in the blood, rectum or bladder during or shortly after treatment was reported.
术前放化疗在宫颈癌T1B - 2ABN0 - 1M0联合治疗中的潜力已得到研究。与单纯放疗相比，使用顺铂使根治性手术的可行性从69%提高到87%，并将2年总生存率和无复发生存率分别从80.8%和77.8%提高到92.6%和89.4%。治疗期间或治疗后不久，血液、直肠或膀胱的并发症发生率未见增加。
